Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/1999
10/28/1999DE19817947A1 New nucleic acid sequences expressed in uterine myoma, and derived polypeptides, for treatment of uterine carcinoma and identification of therapeutic agents
10/28/1999CA2328081A1 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
10/28/1999CA2326623A1 Gene encoding syntaxin interacting protein
10/28/1999CA2325864A1 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy
10/28/1999CA2325848A1 B-cell growth factor related protein
10/28/1999CA2325822A1 Soluble protein ztmpo-1
10/28/1999CA2325663A1 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
10/28/1999CA2325391A1 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999CA2324975A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999CA2324297A1 Sh2 domain-containing peptides
10/28/1999CA2323571A1 Novel human k+ ion channel and therapeutic applications thereof
10/27/1999EP0952222A1 Transgenic plants presenting a modified inulin producing profile
10/27/1999EP0952219A1 Recombinant proteins for the fusion of the porcine reproductive and respiratory syndrome virus and its use in diagnosis
10/27/1999EP0952218A2 Single chain, multiple antigen-binding molecule, its preparation and use
10/27/1999EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999EP0951552A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications
10/27/1999EP0951551A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
10/27/1999EP0951549A1 Mammalian chemokines
10/27/1999EP0951481A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
10/27/1999EP0951480A1 Method and novel compounds for use therein
10/27/1999EP0951479A1 Trh receptor
10/27/1999EP0951477A1 Lymphocyte stimulating factor from trypanosoma
10/27/1999EP0951469A1 Novel compounds
10/27/1999EP0951297A1 Detection of antigens via oligonucleotide antibody conjugates
10/27/1999EP0951296A1 NOVEL FtsL
10/27/1999EP0951295A1 Methods and compositions useful for inhibition of angiogenesis
10/27/1999EP0951292A1 Methods for treating an ischemic disorder and improving stroke outcome
10/27/1999EP0830601B1 Use of a phycobiliprotein-linker peptide complex as a fluorescent tracer
10/27/1999EP0759938A4 Neurogenic differentiation (neurod) genes and proteins
10/27/1999EP0167575B2 Cardiodilatine, a peptide hormone and production process thereof
10/27/1999CN1233290A Antifungal proteins, DNA coding therefore, and hosts incorporating same
10/27/1999CN1233288A GnRH-leukotoxin chimeras
10/27/1999CN1233279A Detergent compositions comprising antibody controlled lipolytic activity
10/27/1999CN1233258A Method for producing an IgM preparation for intravenous administration
10/27/1999CN1233185A Nucleosome-based anti-tumor compositions
10/26/1999USRE36359 Long chain carboxylic acid imide ester
10/26/1999US5973123 Monoclonal antibody, or fragment thereof, which has an affinity for native melanoma inhibitory activity protein
10/26/1999US5973122 Serum immunoregulatory polypeptides and uses therefor
10/26/1999US5973121 The ingestion of peanuts is a common cause of food hypersensitivity reactions.
10/26/1999US5973116 Compounds for targeting
10/26/1999US5972990 Administering angiotensin ii inhibitors, such as losartan to patients who are otherwise free of indications for angiotensin ii inhibition treatment and have left ventricular ejection fraction of 40% or less
10/26/1999US5972901 Making a composition for delivering an oligonucleotide to a mammalian cell by providing a peptide target binding moiety being capable of binding to a serpin enzyme complex receptor, polylysine, an oligonucleotide vector; conjugating, coupling
10/26/1999US5972900 Conjugating target binding moiety consisting of an antibody or fragment which binds to secretory component of polymeric immunoglobulin receptor on surface of epithelium cell, nucleic acid binder, expression vector, compacting, administering
10/26/1999US5972886 Amino acid sequences, a gene coding for stimulating cell differentiation of megakaryocytes; increasing blood platelet cells
10/26/1999US5972884 Morphogen treatment of gastrointestinal ulcers
10/26/1999US5972688 HTm4 methods of treatment and assays, agonists and antagonists
10/26/1999US5972680 An aminopeptidase which is involved in insulin regulation.
10/26/1999US5972676 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
10/26/1999US5972674 May be used, for example, to identify antibodies and other agents that inhibit or activate signal transduction via the nf-.kappa.b cascade.
10/26/1999US5972651 Polynucleotides and polypeptides of the fifty-four homologue family, (ffh); vectors and transformed host cells; ffh are components of protein secretory apparatus and their inhibition of function is deleterious to bacteria cells
10/26/1999US5972646 Isolated nucleic acid molecule which codes for a 32 kDa protein having 11-cis retinol dehydrogenase activity, and which associates with P63, a portion of a retinol binding protein receptor
10/26/1999US5972645 Flea serine protease nucleic acid molecules
10/26/1999US5972633 Antibodies against heart muscle actin
10/26/1999US5972629 Immunoassay to generate patterns of reactivity, then comparing sample to known pattern; for noninvasive diagnosis
10/26/1999US5972628 These antibodies can be used in elisa-test systems for the diagnosis of cancer, to determine the malignancy of cells, to localize a tumor in an organism as well as for the therapy of cancer.
10/26/1999US5972625 Assays for inhibitors of leukocyte adhesion
10/26/1999US5972623 Collagen-peptide assay method
10/26/1999US5972622 Method of detecting apoptosis using an anti-human GP46 monoclonal anti-body
10/26/1999US5972606 A polypeptide; treating osteoporosis, eating disorders, brain disorders, adult respiratory disease syndrome, huntington'sdisease, ulcers, cardiovascular disorders, parkinson's disease;
10/26/1999US5972353 Immunogenic amount of an immunologically active mn protein or m polypeptide effective to immunize a vertebrate against a neoplastic disease associated with expression of mn antigen
10/26/1999US5972349 Synthesis of polyribosylribitol phosphate oligosaccharides
10/26/1999US5972348 Nickel binding protein and its encoding dna isolated from helicobacter pylori; useful as vaccine, diagnostic, drug target, and therapy in itself
10/26/1999US5972347 Pharmaceutical composition containing a neutralized virus and use thereof
10/26/1999US5972338 ?tie? or ?tie? are acronyms, which stand for ?tyrosine kinase containing ig and egf homology domains?; present invention concerns novel human tie ligand homologues with powerful effects on vasculature; antitumor agents
10/26/1999US5972337 46 kilodalton human milk fat globule (HMFG) antigen, fragments and fusion protein
10/26/1999US5972336 Urease-based vaccine against helicobacter infection
10/26/1999US5972335 Compositions for promoting the healing of wounds or fibrotic disorders comprising at least one agent specific to either a growth factor or a protein associated therewith; antibodies
10/26/1999US5972334 Vaccines for treatment of lymphoma and leukemia
10/26/1999CA1340802C Senile amyloid precursor protein and an antibody specific for the same
10/21/1999WO1999053077A1 Novel nep ii membrane metalloprotease and its use for screening inhibitors useful in therapy
10/21/1999WO1999053076A1 Tao protein kinases and methods of use therefor
10/21/1999WO1999053070A1 Flowering locus t (ft) and genetically modified plants having modulated flower development
10/21/1999WO1999053066A1 U4, a member of the hematopoietin receptor superfamily
10/21/1999WO1999053063A1 PEPTIDE LIGAND HAVING SPECIFIC AFFINITY FOR THE HIV1 RETROVIRUS p24 PROTEIN
10/21/1999WO1999053062A2 Isolated sh3 genes associated with myeloproliferative disorders and leukemia, and uses thereof
10/21/1999WO1999053061A2 Tumor associated nucleic acids and uses therefor
10/21/1999WO1999053058A1 Vertebrate patched-2 protein
10/21/1999WO1999053057A1 Protein and gene participating in the differentiation of immortalized cells
10/21/1999WO1999053055A2 Therapeutic agent for ngf
10/21/1999WO1999053054A1 Axor4 g-protein-coupled receptor
10/21/1999WO1999053051A2 5' ests and encoded human proteins
10/21/1999WO1999053049A1 Epitope-driven human antibody production and gene expression profiling
10/21/1999WO1999053047A2 Porcine adenovirus type 3 genome
10/21/1999WO1999053042A2 Biological material with increased expression of endogenous complement regulatory molecules
10/21/1999WO1999053040A2 Human nucleic acid sequences from ovarian tumour tissue
10/21/1999WO1999053036A2 Ste20-related protein kinases
10/21/1999WO1999053020A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae
10/21/1999WO1999052945A2 NOVEL MOLECULES OF THE BGCKr-RELATED PROTEIN FAMILY AND USES THEREOF
10/21/1999WO1999052944A1 G-protein coupled receptors
10/21/1999WO1999052942A2 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma
10/21/1999WO1999052939A1 Peptides
10/21/1999WO1999052938A2 Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites
10/21/1999WO1999052929A1 Nucleic acid sequences and proteins associated with aging
10/21/1999WO1999052924A1 Novel molecules of the t129-related protein family and uses thereof
10/21/1999WO1999052552A1 T cell inhibitory receptor compositions and uses thereof
10/21/1999WO1999052551A1 Therapy of atherosclerosis
10/21/1999WO1999052541A2 Artery- and vein-specific proteins and uses therefor
10/21/1999WO1999052370A1 Nucleic acids encoding outer membrane protein of human granulocytic ehrlichiosis agent
10/21/1999WO1999046574A3 Antibodies for assessing protein post-translational modification status and methods of making and using the same
10/21/1999WO1999046386B1 ALK-1 RESPONDS TO TGF-β AND SIGNALS THROUGH SMAD-1 AND SMAD-5
1 ... 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 ... 1494